Point72 Asia (Singapore) Pte. Ltd. Dynavax Technologies Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $563 Billion
- Q2 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 25,212 shares of DVAX stock, worth $262,204. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,212Holding current value
$262,204% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
293Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$228 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$185 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$87.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$66.5 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$44.8 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.32B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...